Peer-reviewed cost savings. Real-world results.
A study published in the leading health economics journal Value in Health found significant annual cost savings associated with Hello Heart.
The study evaluated 7,112 Hello Heart participants across 14 employers between 2018 and 2023 and compared them to 7,112 matched non-participants.For Fully Insured plans accountable for cost trend and retention, these findings matter.
The study evaluated 7,112 Hello Heart participants across 14 employers between 2018 and 2023 and compared them to 7,112 matched non-participants.For Fully Insured plans accountable for cost trend and retention, these findings matter.
Peer-reviewed cost savings. Real-world results.
A study published in the leading health economics journal Value in Health found significant annual cost savings associated with Hello Heart.
The study evaluated 7,112 Hello Heart participants across 14 employers between 2018 and 2023 and compared them to 7,112 matched non-participants.For Fully Insured plans accountable for cost trend and retention, these findings matter.
The study evaluated 7,112 Hello Heart participants across 14 employers between 2018 and 2023 and compared them to 7,112 matched non-participants.For Fully Insured plans accountable for cost trend and retention, these findings matter.
Our impact on 7,112 users across 14 clients
18%
lower medical spending for Hello Heart users
$1,709
reduction in medical costs per participant per year
>2:1
return-on-investment driven by fewer inpatient days
Fewer inpatient days.
Lower claims exposure.
Inpatient utilization remains one of the most volatile and expensive components of medical spend.
Cost savings driven by fewer hospital days
Hello Heart participants experienced:
- 47% reduction in inpatient days
- Fewer acute care episodes
- Patterns consistent with improved chronic condition management
For plans competing on affordability, reducing inpatient exposure is a strategic lever.
See what this means for your population
Clinically meaningful improvements. Proven financial impact.
Published in Value in Health, this study represents one of the largest peer-reviewed analyses demonstrating real-world financial outcomes from a digital chronic condition self-management program.
Among participants with Stage 2 hypertension:*
16
mmHg
average reduction in systolic BP
11
mmHg
average reduction in diastolic BP
*(baseline systolic ≥140 mm Hg; n=1,243)
Blood pressure improvements were observed across all baseline ranges, with cost savings consistent across employer types, participant sex, and industries. Older participants experienced even greater reductions in spend.
For Fully Insured plans, this means scalable clinical and financial performance across diverse populations.
For Fully Insured plans, this means scalable clinical and financial performance across diverse populations.
See what scalable heart health could unlock for your plan
What this means for Fully Insured plans
Cardiovascular disease remains one of the most persistent cost drivers in commercial populations. When heart health improves consistently, cost performance follows.
Hello Heart is associated with:
- Lower annual medical costs
- Reduced inpatient utilization
- Clinically meaningful blood pressure improvements
- Scalable engagement without operational burden
Request a demo for a detailed review of engagement expectations, financial impact modeling, and performance guarantees.
Ready to move from evidence to impact?
